Project Description


Colzyx develops completely new and innovative wound care and antimicrobial products, which mirror the body’s own wound healing and rebuilding mechanisms in a new evolved way. The initial focus, WOUNDCOM, a bioactive wound dressing, has a proven dual function of accelerating wound healing and having a pronounced effect on a wide range of bacterial infections, including multidrug-resistant bacteria. Hence, WOUNDCOM represents advanced wound care with specific tissue regeneration properties.

Colzyx is led by a highly qualified, interdisciplinary team with broad experience in life science and research successes published in peer-reviewed journals, namely the co-founders Dr. Eskil Söderlind, Dr. Matthias Mörgelin, and Dr. Karin Bryder. Along with a proven track record in bioscience research, the team is highly skilled in business development and project management. Colzyx is located in Lund, Sweden, and joined NOME in 2021.

Company details


More companies